You can buy or sell TLSA and other stocks, options, ETFs, and crypto commission-free!
Tiziana Life Sciences plc American Depository Share, also called Tiziana Life Sciences, is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. Read More The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.
London, Greater London
52 Week High
52 Week Low
Research And Development
Seeking AlphaApr 25
NASH player Tiziana up 40% after Gilead flop
Ultra-thinly traded micro cap Tiziana Life Sciences (TLSA +40.2% ) is up on almost a 10x surge in volume, albeit on turnover of only 17.4K shares, in apparent reaction to the failure of another late-stage study of Gilead Sciences' selonsertib.
-$0.07 per share
Expected May 28, Pre-Market